Peter Collins

Summary

Affiliation: University Hospital of Wales
Country: UK

Publications

  1. doi request reprint Therapeutic challenges in acquired factor VIII deficiency
    Peter W Collins
    Arthur Bloom Haemophilia Centre, School of Medicine, Cardiff University, Cardiff, United Kingdom
    Hematology Am Soc Hematol Educ Program 2012:369-74. 2012
  2. pmc Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
    Peter Collins
    Arthur Bloom Haemophilia Centre, University Hospital of Wales, School of Medicine, Cardiff University, Cardiff, UK
    Blood 120:47-55. 2012
  3. pmc Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
    Peter Collins
    Arthur Bloom Hemophilia centre, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK
    BMC Res Notes 3:161. 2010
  4. doi request reprint Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
    P W Collins
    School of Medicine, Cardiff University and University Hospital of Wales, Cardiff, UK
    Haemophilia 17:2-10. 2011
  5. ncbi request reprint A population based, unselected, consecutive cohort of patients with acquired haemophilia A
    Peter Collins
    Department of Haematology, University of Wales College of Medicine, Cardiff, UK
    Br J Haematol 124:86-90. 2004

Detail Information

Publications5

  1. doi request reprint Therapeutic challenges in acquired factor VIII deficiency
    Peter W Collins
    Arthur Bloom Haemophilia Centre, School of Medicine, Cardiff University, Cardiff, United Kingdom
    Hematology Am Soc Hematol Educ Program 2012:369-74. 2012
    ..Relapse is common (10%-20%) in the first 6 months after immunosuppression is stopped, and patients need to be followed up regularly to allow early diagnosis and treatment of relapse...
  2. pmc Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
    Peter Collins
    Arthur Bloom Haemophilia Centre, University Hospital of Wales, School of Medicine, Cardiff University, Cardiff, UK
    Blood 120:47-55. 2012
    ..Outcome was not affected by the choice of first-line therapy. The likelihood of achieving stable remission was not affected by underlying etiology but was influenced by the presenting inhibitor titer and FVIII level...
  3. pmc Consensus recommendations for the diagnosis and treatment of acquired hemophilia A
    Peter Collins
    Arthur Bloom Hemophilia centre, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK
    BMC Res Notes 3:161. 2010
    ..AHA usually presents to clinicians without prior experience of the disease, therefore diagnosis is frequently delayed and bleeds under treated...
  4. doi request reprint Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia
    P W Collins
    School of Medicine, Cardiff University and University Hospital of Wales, Cardiff, UK
    Haemophilia 17:2-10. 2011
    ..If PK is to be used in routine clinical practice, a simplified method for its measurement is required and this methodology is becoming available...
  5. ncbi request reprint A population based, unselected, consecutive cohort of patients with acquired haemophilia A
    Peter Collins
    Department of Haematology, University of Wales College of Medicine, Cardiff, UK
    Br J Haematol 124:86-90. 2004
    ....